Colony Group’s Immunogen Inc IMGN Stock Holding History

Colony Group’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-104	Closed	-$1K	–	919
2015 Q3	$1K	Buy	+104	New	+$1.52K	﹤0.01%	810

Other funds holding IMGN

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Colony Group's IMGN Position: Q4 2015 in Review

Colony Group sold out of Immunogen Inc (IMGN) in Q4 2015, closing a stake of 104 shares — an estimated $1K sold.

Colony Group first reported a position in IMGN in Q3 2015 and held it in 1 quarter. The position peaked at $1K in Q3 2015. 152 funds tracked by Wall St. Rank hold IMGN as of Q4 2015.

Colony Group reported no remaining Immunogen Inc position as of Q4 2015 after selling out during the quarter.
Colony Group sold 104 Immunogen Inc shares in Q4 2015, an estimated $1K.
Colony Group first reported a position in Immunogen Inc in Q3 2015 and held it in 1 quarter.
Colony Group's Immunogen Inc position peaked at $1K in Q3 2015.
152 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2015.

Based on Colony Group's 13F filing for Q4 2015, filed 19 Feb 2016.